about
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trialHuman recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitisHHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon alphaGender-specific differences in Adamantiades-Behçet's disease manifestations: an analysis of the German registry and meta-analysis of data from the literature.Anatomic-functional (perfusion-based) magnetic resonance imaging follow-up in patients with rheumatoid arthritis treated with anti-interleukin 6 antibodies: a comparison with clinical scores and serologic data.Both pain and EEG response to cold pressor stimulation occurs faster in fibromyalgia patients than in control subjects.EULAR recommendations for the management of Behçet disease.Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease.[EULAR recommendations for the management of Behçet's disease. Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)].Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.Behçet's disease in HLA-B*51 negative Germans and Turks shows association with HLA-Bw4-80IAutologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Aga[Epidemiology and clinical aspects of Adamantiades-Behçet disease in Gemany. Current data].Behçet's disease: ocular effects and treatment.Changes in referral, treatment and outcomes in patients with systemic lupus erythematosus in Germany in the 1990s and the 2000sB cells contribute to heterogeneity of IL-17 producing cells in rheumatoid arthritis and healthy controls.[Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative].The use of interferon-alpha in Behçet's disease--review of the literature and possible mechanisms of action.Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.Evolution of cost structures in rheumatoid arthritis over the past decade.Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a rThe use of interferon alpha in Behçet disease: review of the literature.Autologous stem cell transplantation of treatment-resistant systemic vasculitis--a single center experience and review of the literature.The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement.Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.MRI findings in inflammatory muscle diseases and their noninflammatory mimics.Interferon therapy in rheumatic diseases: state-of-the-art 2010.Imaging of primary and secondary inflammatory diseases involving large and medium-sized vessels and their potential mimics: a multitechnique approach.MRI findings in psoriatic arthritis of the hands.Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.Fertility preservation methods in young women with systemic lupus erythematosus prior to cytotoxic therapy: experiences from the FertiPROTEKT network.Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.TLR9 independent interferon α production by neutrophils on NETosis in response to circulating chromatin, a key lupus autoantigen.Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia.[Autoinflammatory syndromes/fever syndromes].[52-year-old patient with transient exanthema, fever, and arthralgias. Adult-onset Still's disease].[Periodic fever syndrome/autoinflammatory syndrome].[Large vessel vasculitis as cause of fever of unknown origin (FUO) or systemic inflammation. Diagnosis using 18-F-fluor-2-deoxy-D-glucose positron emission tomography ((18)F-FDG-PET)][Behçet's disease: uveitis-therapy with interferon alpha2a - prospective clinical study in 33 patients].Sacroiliitis in sarcoidosis: case reports and review of the literature.
P50
Q19862843-D7B25900-2F7D-445D-BEC0-5FE4084D03DDQ24671749-D701DC21-926C-4079-9286-9E857016D892Q28345040-141474B2-9F0D-444B-808E-9F18A073EB01Q30842385-49FAA5F4-C0B9-4C4B-AABF-5A7D66D9725BQ30857224-2A60776F-E693-4530-9B08-EF75D5395FC0Q31854394-E1EC1BB0-8E7F-40C0-8FFD-F69F53FF9C5DQ33317927-D0D35337-5E74-43A7-95A9-8D9AD8E5439DQ33329054-4D957A25-37F8-4F2C-B324-F00C7941F65EQ33394262-BE130100-97D8-4B33-A6E7-F75FAD02A730Q33632260-C1093C49-036F-4F06-9624-21480543CC49Q33822632-5D554902-8C91-4A47-9E71-9647B3036A80Q33876528-C403FE57-B07D-46F0-B53F-9287FE5AF129Q34304637-25B26677-FD0D-4610-A2E4-B9D6C535F318Q34585314-707F5563-75E2-4D8A-9DCC-068D2B4A0175Q34739465-24E984F4-9B4D-496E-ABBA-ED0DB5591990Q35067840-9720AB25-F0A2-4AA5-B4C1-99667D78BBE9Q35109668-26C7FAE5-EC21-4927-A49B-627C98621336Q35199780-E48F8BDC-F45D-490D-8D8C-7BAAF2172346Q35305133-2CC33657-6408-4865-9968-7CC7437E7D34Q35352526-66983B48-03FA-4ED9-BDBA-35713967FD31Q35638755-97F6C717-2563-4919-9DC1-0E94C2016747Q35744081-C51C0EC6-9ED6-41E3-8360-ED4E331FF4D4Q36349081-C2C21142-F7BD-4F31-8FED-853834AEF33FQ36773107-197B8A1A-DB2E-4B02-9E2F-5A81972F0575Q36855193-FF219FDF-1016-485C-83B8-74A585319859Q37490506-EDE2A8CF-A5F9-496B-999E-F1E57F7433F2Q37671579-520477AC-A796-4E4B-8EDA-10F7B1E2086BQ37696007-91F633A0-75F3-4792-9855-4B9570D076D4Q37802122-C12ED40E-4E5A-443F-9A40-6DD52E4D3F3CQ37954539-A1D10F69-5CDD-42B8-9A71-D82C4BD25A16Q37995966-9510ED25-5993-4F24-B669-FC5233C93822Q38013873-57C8B93B-36D1-4A0A-9321-43F4B4FB243FQ39353950-B3CEC75B-BDBB-4C71-A1C4-EDF1ECA5D1A7Q39376015-69FF5270-F8E2-4550-B2D0-C303D2BD96DBQ40326095-B009A57B-C3C6-47BC-9674-9C2DC06915B0Q40343852-24401543-E736-4F33-B3DA-DF5D3F9FFD55Q40395893-91C75CA6-AB91-41A3-9596-A1AC91A60086Q40513409-F39A257F-8C32-43DA-B2CE-9E0E4AB026F5Q40589645-9FE125C7-D36C-4D77-A9E4-463C36F2B0F1Q40975070-0F518DBC-C395-424A-9407-0236FD1DEF6E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ina Kötter
@ast
Ina Kötter
@en
Ina Kötter
@es
Ina Kötter
@nl
Ina Kötter
@sl
type
label
Ina Kötter
@ast
Ina Kötter
@en
Ina Kötter
@es
Ina Kötter
@nl
Ina Kötter
@sl
prefLabel
Ina Kötter
@ast
Ina Kötter
@en
Ina Kötter
@es
Ina Kötter
@nl
Ina Kötter
@sl
P106
P21
P31
P496
0000-0002-9262-005X